Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 207,820 | 156,544 | 142,131 | 123,744 | 251,098 |
| Marketable Securities | 307,610 | 363,825 | 352,517 | 364,966 | 320,158 |
| Receivables | 2,548 | 3,271 | 3,691 | 42,803 | 42,348 |
| TOTAL | $528,993 | $537,045 | $509,539 | $544,875 | $626,605 |
| Non-Current Assets | |||||
| PPE Net | 5,175 | 5,049 | 4,895 | 5,372 | 5,334 |
| Investments And Advances | 74,614 | 103,920 | 160,354 | 160,198 | 107,846 |
| Other Non-Current Assets | 14,301 | 12,857 | 12,188 | 12,632 | 12,056 |
| TOTAL | $94,090 | $121,826 | $177,437 | $178,202 | $125,236 |
| Total Assets | $623,083 | $658,871 | $686,976 | $723,077 | $751,841 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,249 | 13,999 | 8,503 | 7,154 | 11,055 |
| Accrued Expenses | 61,032 | 21,049 | 29,124 | 26,857 | 20,730 |
| TOTAL | $70,274 | $37,999 | $40,360 | $36,814 | $34,666 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,477 | 1,538 | 1,397 | 1,449 | 1,604 |
| Other Non-Current Liabilities | 59,008 | 57,448 | 56,322 | 54,571 | 53,307 |
| TOTAL | $59,008 | $57,448 | $56,322 | $54,571 | $53,307 |
| Total Liabilities | $129,282 | $95,447 | $96,682 | $91,385 | $87,973 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,205 | 38,274 | 38,194 | 36,534 | 36,522 |
| Common Shares | 44 | 38 | 37 | 37 | 37 |
| Retained earnings | -123,123 | -44,394 | -9,781 | 33,931 | 79,289 |
| Other shareholders' equity | -16,190 | -14,923 | -15,999 | -10,966 | -16,560 |
| TOTAL | $493,801 | $563,424 | $590,294 | $631,692 | $663,868 |
| Total Liabilities And Equity | $623,083 | $658,871 | $686,976 | $723,077 | $751,841 |